Cytogenetic behavior of cryoprotectant DMSO by Papadopoulou, E. et al.
intrODuCtiOn
Robert G. Edwards was awarded the Nobel Prize in
Physiology/Medicine in 2010 because of his scientific
work in reproductive medicine. He is the scientist
who developed in vitro fertilization (IVF), the process
by which an egg is fertilized by sperm in vitro and is
now used worldwide to overcome female or male in-
fertility.
Cryopreservation, a freezing technique, of human
embryos provides the clearest opportunity to improve
the clinical results obtained with IVF and sustain life
for later use.6 
Vitrification, an alternative form of cryopreserva-
tion, is defined as the solidification of a solution
brought about not by crystallization but by extreme
elevation in viscosity during cooling18,19. It is a clinical
practice that allows preservation of fertility potential
in women, involves quick cooling using high concen-
trations of cryoprotectants to minimize freezing in-
juries. It is an attractive ultrarapid cryopreservation
technique.4 The extremely high concentrations of cry-
oprotective agents (CPA) allow the solidification of
a solution below the glass transition temperature,
without ice crystal formation.7,8
Vitrification has been successfully applied to both
cleavage and blastocyst stage embryos and clinical
trials have shown high survival rates and promising
implantation rates following transfer of thawed em-
bryos at all stages.8
CPAs can be classified as penetrating and no pen-
etrating agents. Penetrating agents protect the cell at
slow freezing rates and are more likely to cause cell
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damage by osmotic imbalance and direct toxicity7.
Non penetrating agents form a ‘shield’ around the
cell, thereby reducing freezing injury by minimizing
the effects of dehydration. 
Dimethylsulfoxide (DMSO), a synthetic penetrat-
ing CPA is the best studied CPA.11,20
DMSO is an aprotic solvent. It has a very strong
affinity for water and on exposure to air pure DMSO
is rapidly diluted. Therapeutic and toxic agents that are
not soluble in water are often soluble in DMSO.2,11
DMSO as a cryoprotective agent (CPA) is devel-
oped to substitute a portion of water inside and around
cells, reducing the size of ice crystals and limiting over-
concentration of salts during freezing. However, high
concentrations of CPAs in the vitrification solution
have been shown to be detrimental to the cell; they
can cause cell injuries owing to toxicity.15,23 Despite
the protective effect of CPAs during freezing, they are
toxic to live cells, tissues, and organs (bio-samples)
and CPA toxicity increases with concentration and
contact time in liquid state. CPAs bind to proteins and
other molecules, disrupt multiple bio-chemical path-
ways inside the cells, and cause osmotic imbalance.12,13,14
In order to determine DMSO influence on genetic
stability and/or subsequent DNA repair, we have in-
vestigated its ability to induce Sister Chromatid Ex-
changes (SCEs) and Proliferation Rate Index (PRI)
in normal human lymphocyte cultures of peripheral
blood. SCE frequency has been identified as one of
the most sensitive indices among sensitive biomarkers
of genotoxicity, such as chromosomal aberrations,
comet assay and micronuclei. SCEs can provide insight
in the cytogenetic damage induced by various geno-
toxic agents at very low concentrations. The determi-
nation of PRI in lymphocyte cultures has been proved
to be a very valuable and sensitive indicator of the cy-
tostatic action of various environmental hazards or
therapeutic agents.9,17
MAteriAlS AnD MethODS
The vitrification kit K-SIBV-500 is designed for the
vitrification of embryos and oocytes. In particular,
embryos/oocytes are placed for specific time in 3 so-
lutions that contain 5%, 10% and 20% DMSO respe -
ctively, and then put on a carrier device and plunged
into liquid nitrogen. Due to the fact that the study
cannot be conducted on embryos due to the limited
number of spare available embryos, the corresponding
accessible experimental material was T lymphocyte
cultures from peripheral blood of healthy donors.
After a series of pilot experiments in order to improve
and adapt the process as much as possible close to
the conditions of IVF embryo/oocyte vitrification and
given the fact that there hasn't been a corresponding
survey, peripheral blood was established as experi-
mental material. 
The blood samples were taken from three different
healthy donors 18 to 28 years old, who were non-smok-
ers, not receiving any drugs, not consuming consid-
erable quantities of alcohol, or not having suffered
any kind of infection for the last 15 days.
in vitrO SCeS AnD Pri ASSAyS
1ml heparinized whole blood and 1ml buffer solution
containing respectively 0%, 5%, 10%, and 20% DMSO
were placed in four (4, experimental) falcon tubes.
1ml of heparinized whole blood without any other so-
lution was placed in one falcon tube, which was used
as control. Each of the experimental tubes was kept
at room temperature for different period: for 0min,
5min, 2-4min and 40sec respectively (equivalent to
the cryopreservation protocols in IVF). 
Just after the end of the respective period, in each
tube 5ml of RPMI (RPMI-1640, Biochrome, Berlin) so-
lution was added in order to minimize the action of DM-
SO, centrifugation of the tubes followed for 5min at 1800
rpm and the supernatants were discarded and se diments
consisted of lymphocytes which were treated by the cry-
oprotectants remained in the bottom of the tubes.
Human lymphocyte cultures were prepared by ad -
ding in each tube (containing the corresponding whole
sediment) 5ml chromosome medium (RPMI-1640,
Biochrome, Berlin, supplemented with 20% FCS,
0.63% L-glutamine, 0.63% Penicillin/Streptomycin
and 2% Phytohaemagglutinin), and 0,05ml of 5-Bro-
modeoxyuridine (BrdU) water solution (400 μg/ml)
at the beginning of culture life.
The cultures were incubated at 37οC for 72 hours
in the dark, in order to minimize photolysis of BrdU.
Colchicine (0.3μg/ml) was added 2h before the col-
lection of the cultures. The cells were, then, collected
by centrifugation and exposed to 0.075 M KCl for 10
minutes. The hypotonic solution spreads the chromo-
somes and hemolyses the red blood cells. The pellet
was fixed three times with methanol:acetic acid (3:1).
Drops of concentrated suspension of cells were placed
on microslides that allowed to air dry. For SCEs and
PRI analysis, the slides were stained by a modification
of the Fluorescence Plus Giemsa procedure to obtain
harlequin chromosomes.16
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The same procedure was repeated for the other 2
donors.
StAtiStiCAl AnAlySiS 
For SCEs, more than 30 suitably spread 2nd division
cells from each culture were blindly scored. For PRI,
at least 100 cells in the 1st, 2nd, 3rd and higher divi-
sions from each culture were blindly scored. PRI is
estimated according to: PRI=M1+2M2+3M3+/100,
where M1, M2, and M3+, are the percent values of
cells in the 1st, 2nd, 3rd and higher divisions respec-
tively. For the statistical evaluation of the experimental
data, Student’s t-test was performed to determine
whether any SCE values differed significantly from
the controls and the X2 test was used for the cell ki-
netic comparisons (PRI).9,10 
reSultS
Table 1 and Figure 1 illustrate the cytotoxicity of DM-
SO, presented as dose-dependent increase of SCE fre-
quency. The results show that all three DMSO con-
centrations cause a statistically significant increase of
SCE frequency of the lymphocytes (p<0.001). This
increase is proportional to the increase of the concen-
tration of DMSO. Whereas no statistically significant
difference of SCE frequency was found after comparing
the effect of the same concentration of DMSO (10%)
on two different times (4min and 2min) (p>0.001).
Table 2 and Figure 2 represent the cytostatic effect
of DMSO on cultured human lymphocytes as PRI
values. DMSO has caused a dose-dependent reduction
of PRI values, but this reduction was not statistically
significant (p>0.001). 
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table i. Effect of DMSO solutions (5% 10% and 20%) on SCE frequency in human lymphocyte cultures from three 
different healthy donors.
1st Donor 2nd Donor 3rd Donor
SCEs±SE/cell SCEs±SE/cell SCEs±SE/cell
Control 1st (H2O) 7.96±0.49 7.67±0.41 7.67±0.4
Control 2nd (buffer) 7.1±0.51 7.33±0.424 7.23±0.497
DMSO 5% for 5min 7.98±0.416 7.98±0.402 8.12±0.370*
DMSO 10% for 2min 11.5±0.574* 11.68±0.418* 10.77±0.444*
DMSO 10% for 4min 11.4±0.518* 10.37±0.375* 10.74±0.353*
DMSO 20% for 40sec 13.03±0.511* 13.14±0.462* 12.81±0.447*
*Statistically significant (p<0.001) increase over the corresponding control (t-test)
SE= standard error of the mean
A minimum of 20 cells was scored for SCEs from each culture. 
Figure 1. Effect of DMSO solutions (5% 10% and 20%) on SCE frequency in human lymphocyte cultures 
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DMSO is a clear odorless and colorless organic liquid
that freezes at 18.50ο C. It is an inexpensive element
produced as a by-product of the paper industry.11 DM-
SO has been particularly promoted as an analgesic
and anti-inflammatory agent, whilst it is a compound
that has stimulated much controversy in the scientific
literature.1,2 Adverse reactions of DMSO are common,
though they are usually minor and related to the con-
centration of DMSO in the medication solution.3
As IVF has become more widely available and the
need for the cryopreservation of human embryos has
become apparent, pressure for most effective cry-
oprotectants has increased.6 
While physiologic and pharmacologic properties
and effects of DMSO are incompletely understood,
the research of Branch DR et al has concluded that
DMSO has been the most widely used cryoprotective
agent for human peripheral blood stem cells. It readily
crosses cell membranes, prevents intracellular for-
mation of ice crystals and disruption of cell membranes
under freezing.21 
Kartberg AJ et al 2008 have studied vitrification
on early mouse and human embryos comparing two
vitrification protocols with similar osmolarities, one
containing DMSO and another without DMSO. They
have concluded that vitrification with DMSO protects
embryo membrane integrity better than solutions
without DMSO, but morphological assessment of em-
4 Aristotle University Medical Journal, Vol. 42, Issue 1, February 2015
table 2. Effect of DMSO solutions (5% 10% and 20%) on PRI values in human lymphocyte cultures from three 
different healthy donors.
1st Donor 2nd Donor 3rd Donor
Control 1st (H2O) 2.34 2.23 2.2
Control 2nd (buffer) 2.3 2.12 2.13
DMSO 5% for 5min 1.78 2.04 1.88
DMSO 10% for 2min 1.71 1.99 1.8
DMSO 10% for 4min 1.7 1.99 1.79
DMSO 20% for 40sec 1.67 1.83 1.67
Figure 2. Effect of DMSO solutions (5% 10% and 20%) on PRI values in human lymphocyte cultures 
from three different healthy donors. 
Control 5% for 5 min 5% for 4 min
Bu!er 10% for 2 min 20% for 40 min
Concentration DMSO %
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bryos directly after vitrification was not a useful tool
for assessing survival in that study.5
Recently Seet VY et al 2013 have investigated the
detrimental effects of cryoprotectants on oocyte quality
based on the morphological appearance of the oocyte.
The results of their study indicate that observations
based purely on the morphological appearance of the
oocyte to assess the cryosurvival rate are insufficient
and sometimes misleading.4
Chatzimeletiou et al., 2011 have provided the first
cytoskeletal analysis of human vitrified blastocysts
comparing the type and incidence of spindle abnor-
malities, to those observed in fresh blastocysts. The
authors concluded that vitrification does not adversely
affect embryo development and the ability of spindles
to form and continue normal divisions. The majority
of spindle/chromosome configurations analyzed were
indeed normal, but the incidence of spindle abnor-
malities (including abnormal shape, chromosome lag-
ging, bridging and multipolarity) were higher in the
vitrified group compared to the fresh group. It is un-
clear whether the increase in spindle abnormalities
following vitrification is due to toxicity or mechanical
stress following exposure to the high concentrations
of cryoprotectants or due to the submersion into liquid
nitrogen.8
Chatzimeletiou et al., 2010 suggested that the ex-
posure to the cryoprotectants causes the cells to shrink
and gives rise to the abnormally shaped spindles which
are observed in the vitrified blastocysts. If this abnor-
mality in morphology is superficial and these abnor-
mally shaped spindles complete mitosis normally it
is likely that the derivative cells will be normal. How-
ever, if this abnormality in the shape of the spindle is
conjugated with a function abnormality, it is possible
that the spindle will either fail to progress further or
if it progresses through mitosis the derivative cells
may have an abnormal chromosomal constitution.
This is certainly the case for the multipolar spindles
that can lead to chaotic chromosomal divisions and
the spindles that are associated with chromosome lag-
ging, in which the derivative cells will be affected by
chromosome loss, and consequently will become
monosomic. Both of these cases may reflect mecha-
nisms that can lead to chromosomal mosaicism in
early human development.22
Whereas DMSO has received intense lay publicity
sporadically over the last four decades studies have
not been performed on its effect on DNA, indicating
that cytogenetic activity of this effective cryoprotectant
has been ignored so far, to the best of our knowledge. 
So in order to investigate the cytogenetic behavior
of DMSO in the concentrations that are used during
vitrification of embryos, we have conducted the present
research. Lymphocytes from peripheral blood of three
different young healthy donors have been treated with
DMSO solutions contained in the embryo vitrification
kit K-SIBV-500 according to the manufacturer’s in-
structions. Then these lymphocytes were cultured in
the presence of Brdu and processed for Sister Chro-
matid Exchanges (SCEs) and Proliferation Rate Index
(PRI).
All tested DMSO concentrations, 5%, 10% and
20%, have induced the SCE frequency of cultured
lymphocytes and the induction has been presented as
dose-dependent increase of SCEs, statistically signif-
icant (p<0.001). The cytogenetic effect of 10% DMSO
solution on lymphocytes has been tested for two dif-
ferent times (4min and 2min) of treatment. The results
have revealed that the effect of DMSO for an addi-
tional 2 minutes treatment does not alter the cytoge-
netic behavior of the cryoprotectant. The statistically
significant increase of SCE frequency of human lym-
phocytes which has been induced by DMSO solutions
suggests that at least these specific concentrations of
the cryoprotectant exert cytotoxic activity. In other
words, the effect of DMSO on lymphocytes appear
to cause instability or/and damages to their DNA
molecule that the repair mechanisms of the cell are
not able to repair.
The results of the study also suggest that the 5%,
10% and 20% DMSO solutions after 5min, 2min and
40 exposure on lymphocytes respectively have caused
a dose-dependent reduction of PRI values, but this
reduction was not statistically significant (p>0.001).
Diminution of PRI values means decrease of Prolif-
eration Rate of cultured lymphocytes. So the specific
DMSO solutions could be characterized as mild cy-
tostatic. 
This is the first study to investigate the cytotoxicity
of the DMSO concentrations used in IVF vitrification
protocols, by mimicking the exposure times and con-
centrations in blood lymphocytes. Our results show
an increase SCEs and raise the need for more research
regarding the safe and effective use of cryoprotectant
methodologies for the vitrification of cells, gametes
and embryos.
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Κυτταρογενετική επίδραση διαλυμάτων του κρυοπροστατευτικού DMSO
Παπαδοπούλου Ε, Χατζημελετίου Κ, Σύρρου Μ, Καλινδέρης A, Ιακωβίδου-Κρίτση Ζ.
Περiληψη: Στην μείωση της υπογονιμότητας συμβάλλει σημαντικά η εξωσωματική γονιμοποίηση, κατά την διαδικασία
της οποίας για την συντήρηση και εμβρυομεταφορά απαιτούνται διάφορα κρυοπροστατευτικά διαλύματα. Στην πλειοψηφία
των διαλυμάτων αυτών δραστική ουσία αποτελεί το DMSO (διμεθυλοσουλφοξείδιο) σε συγκεντρώσεις 5%, 10% και 20%,
η κυτταρογενετική δράση των οποίων δεν έχει μελετηθεί. Στόχος της παρούσας έρευνας είναι η διερεύνηση των συγκεκριμένων
συγκεντρώσεων DMSO στο γενετικό υλικό καλλιεργημένων λεμφοκυττάρων περιφερικού αίματος φυσιολογικών ατόμων,
επειδή η μελέτη δεν είναι δυνατόν να διεξαχθεί σε ανθρώπινα έμβρυα. 
Για τις καλλιέργειες των λεμφοκυττάρων χρησιμοποιήθηκε ηπαρινισμένο αίμα από 3 φυσιολογικά νεαρά άτομα (διεξαγωγή
πειραματικής διαδικασίας εις τριπλούν). Μετά την επίδραση των διαλυμάτων DMSO ( 5%, 10% και 20%) στο ολικό αίμα,
σύμφωνα με τις οδηγίες του kit K-SIBV-500, συλλέγονται τα λεμφοκύτταρα και καλλιεργούνται με την κατάλληλη τεχνική
ώστε να εκτιμηθούν οι SCEs (συχνότητα χρωματιδιακών ανταλλαγών), από τους πιο ευαίσθητους δείκτες κυτταροτοξικότητας
και ο PRI (δείκτης ρυθμού πολλαπλασιασμού κυττάρων), αξιόπιστος δείκτης κυτταροστατικότητας.
Τα αποτελέσματα που προέκυψαν δείχνουν στατιστικά σημαντική αύξηση των SCEs (p<0.001) των λεμφοκυττάρων
αντίστοιχη με την αύξηση της συγκέντρωσης του DMSO, εύρημα που ενοχοποιεί τις συγκεκριμένες συγκεντρώσεις για
κυτταρογενετική δράση, γεγονός που πρέπει να ληφθεί σοβαρά υπ’ όψιν στην προσπάθεια ελαχιστοποίησης των βλαπτικών
συνθηκών κατά την εξωσωματική γονιμοποίηση. 
Λέξεις κλειδιά: DMSO, κυτταρογενετικές επιδράσεις, χρωματιδιακές ανταλλαγές
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